Cash & equivalents decreased 55.1%
Cash & equivalents changed -55.1% from the comparable as-filed period.
$3.2M→$1.4M2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →FEMY financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating income decreased 31.5%
Operating income changed -31.5% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
-$3.9M→-$5.1M4 prior comparisons
Operating margin moved 58557 bp lower
Operating margin changed -58557 basis points from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
-941.09%→-1526.66%4 prior comparisons
Research & development increased 37.6%
Research & development changed +37.6% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$1.4M→$1.9M4 prior comparisons
Inventory increased 18.3%
Inventory changed +18.3% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$5.2M→$6.2M4 prior comparisons
Revenue decreased 18.9%
Revenue changed -18.9% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$409,268→$331,8274 prior comparisons
Stock-based compensation increased 15.9%
Stock-based compensation changed +15.9% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$181,971→$210,8204 prior comparisons
Net income increased 2.5%
Net income changed +2.5% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
-$4.6M→-$4.5M4 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.